04:52 PM EDT, 09/12/2024 (MT Newswires) -- Samuel C. Blackman, Head of R&D, on September 10, 2024, sold 30,000 shares in Day One Biopharmaceuticals ( DAWN ) for $426,675. Following the Form 4 filing with the SEC, Blackman has control over a total of 2,097,535 shares of the company, with 1,097,535 shares held directly and 1,000,000 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1845337/000141588924023298/xslF345X05/form4-09122024_080954.xml

Price: 13.66, Change: -0.01, Percent Change: -0.07